-
1
-
-
7344248007
-
Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma: The Dutch Asthma Study Group
-
Verberne AA, Frost C, Duiverman EJ, et al. Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma: the Dutch Asthma Study Group. Am J Respir Crit Care Med 1998; 158:213-219
-
(1998)
Am J Respir Crit Care Med
, vol.158
, pp. 213-219
-
-
Verberne, A.A.1
Frost, C.2
Duiverman, E.J.3
-
2
-
-
0034008825
-
Long-acting β(2)-agonists in management of childhood asthma: A critical review of the literature
-
Bisgaard H. Long-acting β(2)-agonists in management of childhood asthma: a critical review of the literature. Pediatr Pulmonol 2000; 29:221-234
-
(2000)
Pediatr Pulmonol
, vol.29
, pp. 221-234
-
-
Bisgaard, H.1
-
3
-
-
0142126269
-
2 agonists on exacerbation rates of asthma in children
-
2 agonists on exacerbation rates of asthma in children, Pediatr Pulmonol 2003; 36:391-398
-
(2003)
Pediatr Pulmonol
, vol.36
, pp. 391-398
-
-
Bisgaard, H.1
-
4
-
-
31444434173
-
2 agonists and paediatric asthma
-
2 agonists and paediatric asthma. Lancet 2006; 367:286-288
-
(2006)
Lancet
, vol.367
, pp. 286-288
-
-
Bisgaard, H.1
Szefler, S.2
-
5
-
-
0036841323
-
Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma
-
Tal A, Simon G, Vermeulen JH, et al. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma. Pediatr Pulmonol 2002; 34:342-350
-
(2002)
Pediatr Pulmonol
, vol.34
, pp. 342-350
-
-
Tal, A.1
Simon, G.2
Vermeulen, J.H.3
-
6
-
-
0036706907
-
One-year efficacy and safety of inhaled formoterol dry powder in children with persistent asthma
-
Bensch G, Berger WE, Blokhin BM, et al. One-year efficacy and safety of inhaled formoterol dry powder in children with persistent asthma. Ann Allergy Asthma Immunol 2002; 89: 180-190
-
(2002)
Ann Allergy Asthma Immunol
, vol.89
, pp. 180-190
-
-
Bensch, G.1
Berger, W.E.2
Blokhin, B.M.3
-
7
-
-
0038498556
-
Serious asthma exacerbations in asthmatics treated with high-dose formoterol
-
Mann M, Chowdhury B, Sullivan E, et al. Serious asthma exacerbations in asthmatics treated with high-dose formoterol. Chest 2003; 124:70-74
-
(2003)
Chest
, vol.124
, pp. 70-74
-
-
Mann, M.1
Chowdhury, B.2
Sullivan, E.3
-
8
-
-
1642433318
-
Efficacy and safety of formoterol Turbuhaler when added to inhaled corticosteroid treatment in children with asthma
-
Zimmerman B, D'Urzo A, Berube D. Efficacy and safety of formoterol Turbuhaler when added to inhaled corticosteroid treatment in children with asthma. Pediatr Pulmonol 2004; 37:122-127
-
(2004)
Pediatr Pulmonol
, vol.37
, pp. 122-127
-
-
Zimmerman, B.1
D'Urzo, A.2
Berube, D.3
-
9
-
-
10744222040
-
Formoterol as relief medication in asthma: A worldwide safety and effectiveness trial
-
Pauwels RA, Sears MR, Campbell M, et al. Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial. Eur Respir J 2003; 22:787-794
-
(2003)
Eur Respir J
, vol.22
, pp. 787-794
-
-
Pauwels, R.A.1
Sears, M.R.2
Campbell, M.3
-
10
-
-
0030457409
-
Noncompliance and treatment failure in children with asthma
-
Milgrom H, Bender B, Ackerson L, et al. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996; 98:1051-1057
-
(1996)
J Allergy Clin Immunol
, vol.98
, pp. 1051-1057
-
-
Milgrom, H.1
Bender, B.2
Ackerson, L.3
-
11
-
-
85030508063
-
-
Global Initiative for Asthma: global strategy for asthma management and prevention. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute, 2003; publication No. 02-3659
-
Global Initiative for Asthma: global strategy for asthma management and prevention. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute, 2003; publication No. 02-3659
-
-
-
-
12
-
-
0034523602
-
Clinical management of asthma in 1999: The Asthma Insights and Reality in Europe (AIRE) study
-
Rabe KF, Vermeire PA, Soriano JB, et al. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000; 16:802-807
-
(2000)
Eur Respir J
, vol.16
, pp. 802-807
-
-
Rabe, K.F.1
Vermeire, P.A.2
Soriano, J.B.3
-
13
-
-
0031914524
-
A randomized trial comparing peak expiratory flow and symptom self-management plans for patients with asthma attending a primary care clinic
-
Turner MO, Taylor D, Bennett R, et al. A randomized trial comparing peak expiratory flow and symptom self-management plans for patients with asthma attending a primary care clinic. Am J Respir Crit Care Med 1998; 157:540-546
-
(1998)
Am J Respir Crit Care Med
, vol.157
, pp. 540-546
-
-
Turner, M.O.1
Taylor, D.2
Bennett, R.3
-
14
-
-
84921430993
-
Self-management education and regular practitioner review for adults with asthma
-
CD001117
-
Gibson PG, Powell H, Coughlan J, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2003; 1:CD001117
-
(2003)
Cochrane Database Syst Rev
, pp. 1
-
-
Gibson, P.G.1
Powell, H.2
Coughlan, J.3
-
15
-
-
0942278956
-
Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: Randomised controlled trial
-
Harrison TW, Oborne J, Newton S, et al. Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet 2004; 363:271-275
-
(2004)
Lancet
, vol.363
, pp. 271-275
-
-
Harrison, T.W.1
Oborne, J.2
Newton, S.3
-
16
-
-
3142517969
-
Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations
-
FitzGerald JM, Becker A, Sears MR, et al. Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations. Thorax 2004; 59:550-556
-
(2004)
Thorax
, vol.59
, pp. 550-556
-
-
FitzGerald, J.M.1
Becker, A.2
Sears, M.R.3
-
17
-
-
12144270425
-
Budesonide/ formoterol combination therapy as both maintenance and reliever medication in asthma
-
O'Byrne PM, Bisgaard H, Godard PP, et al. Budesonide/ formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005; 171:129-136
-
(2005)
Am J Respir Crit Care Med
, vol.171
, pp. 129-136
-
-
O'Byrne, P.M.1
Bisgaard, H.2
Godard, P.P.3
-
18
-
-
1842370350
-
Effect of inhaled formoterol and budesonide on exacerbations of asthma: Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group
-
Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma: Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997; 337:1405-1411
-
(1997)
N Engl J Med
, vol.337
, pp. 1405-1411
-
-
Pauwels, R.A.1
Lofdahl, C.G.2
Postma, D.S.3
-
19
-
-
0346726161
-
Ethical assessment of clinical asthma trials including children subjects
-
Coffey MJ, Wilfond B, Ross LF. Ethical assessment of clinical asthma trials including children subjects. Pediatrics 2004; 113:87-94
-
(2004)
Pediatrics
, vol.113
, pp. 87-94
-
-
Coffey, M.J.1
Wilfond, B.2
Ross, L.F.3
-
20
-
-
1842482231
-
Changing requirements for evaluation of pharmacologic agents
-
Chesney RW, Christensen ML. Changing requirements for evaluation of pharmacologic agents. Pediatrics 2004; 113(4 Suppl):1128-1132
-
(2004)
Pediatrics
, vol.113
, Issue.4 SUPPL.
, pp. 1128-1132
-
-
Chesney, R.W.1
Christensen, M.L.2
-
21
-
-
85030500531
-
-
U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for industry recommendations for complying with the pediatric rule (21 CFR 314.55(a) and 601.27(a)). Available at: www.fda.gov/cder/ guidance/3578dft.htm#P128_3875. 1-11-2000. 5-10-0005. Accessed July 1, 2006
-
U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for industry recommendations for complying with the pediatric rule (21 CFR 314.55(a) and 601.27(a)). Available at: www.fda.gov/cder/ guidance/3578dft.htm#P128_3875. 1-11-2000. 5-10-0005. Accessed July 1, 2006
-
-
-
-
22
-
-
85030523815
-
-
U.S. Food and Drug Administration, July 30-31, Bethesda, MD. Available at:, Accessed August 24
-
U.S. Food and Drug Administration. Pulmonary Allergy Advisory Committees Meeting, July 30-31, 1998, Bethesda, MD. Available at: www.fda.gov/ohrms/ dockets/ac/98/transept/ 3430t1.pdf. Accessed August 24, 2006
-
(1998)
Pulmonary Allergy Advisory Committees Meeting
-
-
-
24
-
-
0034642066
-
Long-term effects of budesonide or nedocromil in children with asthma: The Childhood Asthma Management Program Research Group
-
CAMP
-
CAMP. Long-term effects of budesonide or nedocromil in children with asthma: The Childhood Asthma Management Program Research Group. N Engl J Med 2000; 343:1054-1063
-
(2000)
N Engl J Med
, vol.343
, pp. 1054-1063
-
-
-
25
-
-
0031750702
-
Potential masking effects of salmeterol on airway inflammation in asthma
-
Mcivor RA, Pizzichini E, Turner MO, et al. Potential masking effects of salmeterol on airway inflammation in asthma. Am J Respir Crit Care Med 1998; 158:924-930
-
(1998)
Am J Respir Crit Care Med
, vol.158
, pp. 924-930
-
-
Mcivor, R.A.1
Pizzichini, E.2
Turner, M.O.3
|